Filtered By:
Source: Diabetes, Obesity and Metabolism
Condition: Diabetes Mellitus
Cancer: Cancer
Drug: Actos

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Observational follow‐up of the PROactive study: a 6‐year update†
ConclusionsThese data suggest that improved macrovascular outcomes seen with pioglitazone subside without continued pioglitazone treatment. The double‐blind period bladder cancer imbalance did not persist in follow‐up.
Source: Diabetes, Obesity and Metabolism - August 19, 2013 Category: Endocrinology Authors: E. Erdmann, E. Song, R. Spanheimer, A.‐R. van Troostenburg de Bruyn, A. Perez Tags: ORIGINAL ARTICLE Source Type: research